Experimental Study of Preventive Effect of Tetramethylpyrazine-Eluting Stents on In-Stent Restenosis

LI Xuan,CHEN Zhong,MA Gen-shan,SU Ya-min,GU Xing-zhong
DOI: https://doi.org/10.3969/j.issn.1671-6264.2008.02.008
2008-01-01
Abstract:Objective To assess the preventive effect and mechanism of tetramethylpyrazine(TMP)-eluting stents(TES)on in-stent restenosis in pigs.Methods Nine pigs were randomly divided into TES group,bare-metal stents(BMS) group and sirolimus-eluting stents(SES) group.The TES group was implanted with TES,the BMS group with BMS,the SES group with SES.At the 28th day,animals were executed and neointimal thicknesses,proliferating cell nuclear antigen(PCNA) of vascular smooth muscle cell(VSMC),apoptosis of VSMC were measured.Scan electron microscope was used to observe the covering instances of endothelial cells.Results Comparing with BMS,luminal area was significantly increased in the TES group(P0.05),while neointimal area and percentage of restenosis were significantly decreased in the TES group(P0.05).The positive ratio of PCNA of BMS group was higher than that of TES group(P0.05).The positive ratio of PCNA of TES group was higher than that of SES group.The apoptosis was significantly increased in TES group than that in BMS group(P0.05).Scan electron microscope indicated complete reendothelialization at the 28th day in BMS and TES groups,but poor endothelium covering in the SES group.Conclusion TES can inhibit the hyperplasia and migration of VSMC and increase VSMC apoptosis,but it has no effect on the healing of endothelium.TES is a promising and new strategy in preventing restenosis.
What problem does this paper attempt to address?